RE: Sotrovimab - from GSK29 Jul 2021 09:12
Not really Pokerchips. As Ron said in his report yesterday to quote as you always like to do....
You can also find the story of ArtemiC and CimetrA. We have developed, tested, and brought to market not one but two products that have the potential to significantly impact the daily horror we are going through globally with COVID. One, a food supplement that has been clinically proven to arrest the Cytokine Storm, which we took through Phase IIb trials, and the second, a phytomedicine poised to not only demonstrate significant results for COVID treatment but also for a host of other indications that carry the cytokine storm with them as a potential side effect – giving CimetrA a much longer product life than the length of this current pandemic.